Anika Therapeutics (ANIK) Bɛn Dɛŋɛn Akɔc
Anika Therapeutics
Bɛ̈ny cɔk aya$20.40Aciic 25 Sep 2026 19:59 UTC
Change+0.54%
AI forecast: ANIK
AI ekek aŋok wɛlɛɛl bɛn bɛn lɔŋɔŋ, bɛn bɛn cɔlɔŋ, kɛ bɛn bɛn cɔlɔŋ. Cɔkɔkɔkɔ cɔlɔŋ bɛn bɛn lɔŋɔŋ. Aŋok wɛlɛɛl aŋok wɛlɛɛl, aŋok wɛlɛɛl aŋok wɛlɛɛl.
Bɛn cɔk ɛcɔk 6
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Nyɛn cɔk aya bɛn
Ditëëk ë bɛ̈ɛ̈r ë cë lɔ – ditëëk ë cë lɔ kee aköl aköl ë bɛ̈ɛ̈r ë cë lɔ – aye Premium.
Unlock PremiumBɛn kɔc ke bɛn
Anika Therapeutics, Inc. develops, manufactures, and commercializes therapeutic products and devices. The company’s hyaluronic acid-based products promote the repair, protection, and healing of bone, cartilage, and soft tissue. Anika’s product portfolio includes ORTHOVISC and HYVISC, which are used to treat osteoarthritis.
